These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1006062)

  • 1. Migration and fate of Schistosoma mansoni in mice treated with oxaminiquine.
    Oliveira MA; Pellegrino J; Pereira LH; Valadares TE
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):298-300. PubMed ID: 1006062
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic evaluation of oxamniquine in schistosomiasis mansoni by the oogram method with biopsy of rectal mucosa].
    da Cunha AS
    Rev Inst Med Trop Sao Paulo; 1982; 24(2):88-94. PubMed ID: 6753086
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of schistosomiasis mansoni with a combination of oxamniquine and praziquantel. I--Experimental observations related to the pre-patent phase].
    Campos R; Pinto PL; de Sant'Ana EJ; Moreira AA; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(5):201-3. PubMed ID: 3135570
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary laboratory trials with oxamniquine as a prophylactic agent in schistosomiasis.
    Pellegrino J; Pereira LH; Mello RT
    Rev Inst Med Trop Sao Paulo; 1976; 18(2):97-101. PubMed ID: 1273410
    [No Abstract]   [Full Text] [Related]  

  • 5. Observations on the treatment of mansoni schistosomiasis with oxamniquine.
    Pedro RD; Dias LC; Amato Neto V; De Carvalho SA
    Rev Bras Pesqui Med Biol; 1979 Jun; 12(2-3):207-11. PubMed ID: 515473
    [No Abstract]   [Full Text] [Related]  

  • 6. Observations of the treatment of mansoni schistosomiasis with oxamniquine: efficacy in children and in persistent salmonellosis; resistance of a strain of Schistosoma mansoni; hepatic toxicity and neurological side effects.
    Pedro Rde J; de Souza Dias LC; Amato Neto V; de Carvalho SA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):32-6, 148-52. PubMed ID: 7455507
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of oxamniquine on some biological features of schistosomiasis in white mice.
    Hammouda NA; El-Ridi AM; Abu Senna HO; Nasr NT; El-Sawi MF; El-Sawi M; Salama MM
    J Egypt Soc Parasitol; 1983 Jun; 13(1):147-53. PubMed ID: 6631092
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary clinical trial of oral oxamniquine in the treatment of Schistosoma mansoni in Ethiopia.
    Ayele T
    East Afr Med J; 1984 Aug; 61(8):632-6. PubMed ID: 6399027
    [No Abstract]   [Full Text] [Related]  

  • 9. Schistosoma mansoni treatment with oral oxamniquine in Zambia.
    Gupta KK
    East Afr Med J; 1984 Aug; 61(8):641-4. PubMed ID: 6399028
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase].
    Campos R; Pinto PL; Amato Neto V; Moreira AA
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic evaluation of oxamniquine in schistosomiasis mansoni].
    de Almeida FM; Vilela MP; Pricoli TI; Salem N; Guimarães RX; Ferraz CN; Arroyo JB; Fukuda Y; Cabeca M; Geocze S; Tancredi Neto A
    AMB Rev Assoc Med Bras; 1979 Mar; 25(3):101-4. PubMed ID: 315583
    [No Abstract]   [Full Text] [Related]  

  • 12. Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent.
    da Silva LC; Sette H; Chamone DA; Sáez-Alquezar A; Punskas JA; Raia S
    Rev Inst Med Trop Sao Paulo; 1975; 17(5):307-11. PubMed ID: 1198006
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic-protective activity of oral oxamniquine against Schistosoma mansoni infection in hamsters.
    Girgis NI; Mansour NS; Kahlil SB
    East Afr Med J; 1979 Sep; 56(9):428-30. PubMed ID: 520260
    [No Abstract]   [Full Text] [Related]  

  • 14. Susceptibility of Schistosoma mansoni prevalent in Saudi Arabia to oxamniquine in experimentally infected mice.
    Amin AM; Mikhail EG
    J Trop Med Hyg; 1988 Aug; 91(4):192-5. PubMed ID: 3136251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of oxamniquine in the treatment of S. mansoni infection among Sudanese patients.
    Ibrahim AM
    East Afr Med J; 1980 Aug; 57(8):566-73. PubMed ID: 7408738
    [No Abstract]   [Full Text] [Related]  

  • 16. Schistosoma mansoni: ultrastructure of adults from mice treated with oxamniquine.
    Popiel I; Erasmus DA
    Exp Parasitol; 1984 Dec; 58(3):254-62. PubMed ID: 6499999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxamniquine (Vansil) in the treatment of Schistosoma mansoni infections in Rhodesia.
    de V Clarke V
    Cent Afr J Med; 1977 Nov; 23(11 Suppl):20-3. PubMed ID: 606374
    [No Abstract]   [Full Text] [Related]  

  • 18. The circumoval precipitin test as a control of cure in the experimental schistosomiasis mansoni.
    de Mello RT; Pereira LH; Pellegrino J
    Rev Inst Med Trop Sao Paulo; 1979; 21(1):1-4. PubMed ID: 112662
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose.
    da Silva LC; Sette Júnior H; Christo C; Sette PC; Kaye B
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):58-64, 175-81. PubMed ID: 7455511
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of oxamniquine in Schistosoma mansoni bilharziasis in Madagascar in a hospital milieu].
    Queinnec J; Moyroud J
    Arch Inst Pasteur Madagascar; 1981; 48(1):143-9. PubMed ID: 7342891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.